BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Go back to BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update

BioLineRx (BLRX) Tops Q2 EPS by 14c

August 18, 2021 7:03 AM EDT

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.01).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

... More